Skip to main
IDXG

Interpace Diagnostics (IDXG) Market Capitalization Overview

Market Cap: $41.93M as of Aug 31, 2026

$41.93M
$95.60K (0.23%)past month
As of Aug 31, 2026, Interpace Diagnostics (IDXG) has a market capitalization of $41.93M. Over the past 30 days, its market cap has decreased by -1.24%, while in the last 12 months, it has increased by 669.58%.

Market capitalization represents the total value of Interpace Diagnostics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Interpace Diagnostics (IDXG) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Interpace Diagnostics (IDXG) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Interpace Diagnostics (IDXG) Market Cap History

DateMarket CapChange
Aug 3, 2026$44.05M-1.24%
Jul 1, 2026$44.60M-6.40%
Jun 1, 2026$47.65M-18.87%
May 1, 2026$58.73M+14.59%
Apr 1, 2026$51.25M+539.33%
Mar 2, 2026$8.02M+6.03%
Feb 2, 2026$7.56M+43.44%
Jan 2, 2026$5.27M+34.46%

Interpace Diagnostics (IDXG) End of Year Market Cap History

DateMarket CapChange
2026$41.93M+669.58%
2025$5.45M-54.20%
2024$11.90M+154.83%
2023$4.67M+5.69%
2022$4.42M-85.91%
2021$31.34M

FAQs About Interpace Diagnostics (IDXG) Market Cap

As of Aug 31, 2026, the market capitalization of Interpace Diagnostics (IDXG) is $41.93M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Interpace Diagnostics’s market capitalization has decreased by -0.2300%, changing from $42.03M to $41.93M as of Aug 31, 2026.

In the last 3 months, Interpace Diagnostics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Interpace Diagnostics’s market capitalization decreased from $11.90M in January to $5.45M in December, reflecting a -54.2% change.

In the past five years, Interpace Diagnostics (IDXG) has had a compound annual growth rate (CAGR) of -29.53% in market capitalization. This means its market cap has shrunk at an average rate of -29.53% per year.

Interpace Diagnostics (IDXG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.